OOIR: Observatory of International Research

Papers

(The median citation count of Circulation-Cardiovascular Interventions is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Novel Antithrombotic Strategies After Surgical Bioprosthetic Valve Replacement	166
Adjunctive Imaging and Physiology During PCI Among Black and White Medicare Beneficiaries: Disparities in Utilization Patterns and Outcomes	100
The Beaten Path: Use of the Radial Artery as a Bypass Graft After Instrumentation	80
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial	76
Impacts of Hospital Volume and Patient-Hospital Distances on Outcomes of Older Adults Receiving Percutaneous Microaxial Ventricular Assist Devices for Cardiogenic Shock	73
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI	67
Is Stable CAD the Same in All Circumstances? The Curious Case of PCI Before TAVR	64
Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease	61
Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation	54
Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE	54
Fatal Steam Pop Complicating Investigational SESAME Transcatheter Myotomy Using Off-the-Shelf Equipment	54
ACURATE neo2 Versus SAPIEN 3 Ultra Transcatheter Heart Valve in Severe Aortic Valve Calcification: A Propensity-Matched Analysis	54
Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial	53
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry	46
Percutaneous Balloon–Expandable Stent Implantation to Treat Transverse Aortic Arch Obstruction: Medium- to Long-Term Outcomes of a Retrospective Multicenter Study	45
Perfect Wedding Between Patient With STEMI and Angiography-Derived Indexes of Coronary Physiology	44
Supplementing Randomized Trial Data to Answer a Real-World Question: Discharge to Home Status as a Heuristic for Stroke Severity After TAVR	42
Letter by Güner et al Regarding Article, “Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection”	41
Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 t	38
Preventing Complications of Mechanical Circulatory Support Devices: The Clue for Improved Outcomes?	37
Angina After Percutaneous Coronary Intervention?	37
Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction	37
Prognostic Implications of Bleeding and Ischemic Complications in Acute Myocardial Infarction-Related Cardiogenic Shock Managed With Microaxial Flow Pump	36
Giant Aberrant Vascular Structure Extending From the Left Ventricular Apex to the Umbilicus in a Newborn With Cantrell Pentalogy: Management and Transcatheter Closure	36
Response by Yamamoto et al to Letter Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”	35

Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial	35
Timing of Intervention and Long-Term Outcomes in Mild Congenital Heart Disease: A 35-Year Study From the Pediatric Cardiac Care Consortium	35
Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials	34
Letter by Skalidis et al Regarding Article, “Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention”	34
Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials	34
Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions	33
Intravascular Imaging for Optimal Left Main Percutaneous Coronary Intervention: A Requirement Rather Than an Option	33
Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis	32
Letter by Garmendia and Garcia-Garcia Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention”	31
Tricuspid Clip at 2 Years: Clocking the Development of a Rapidly Expanding Space	30
Workflow for Percutaneous Coronary Intervention With Optical Coherence Tomography-Guidance: MAXing the MLD?	29
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial	27
Will a Conservative Case Selection Strategy Improve Hospital-Level TAVR Performance Metrics?	27
Simple Maneuver to Improve TriClip Eligibility in Patients With Cardiac Implantable Electronic Device Leads	26
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study	25
A Tale of Two Polymers: Bioprosthetic Valve Remodeling Versus Bioprosthetic Valve Fracture of Mosaic Surgical Valves to Facilitate VIV TAVR	25
Microvascular Function and Ambulatory Capacity in Peripheral Artery Disease	25
Composite Pulmonary Embolism Shock Score and Risk of Adverse Outcomes in Patients With Pulmonary Embolism	25
Microvascular and Macrovascular Disease: The S’mores of Peripheral Artery Disease	25
Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: Lessons Learned After the Learning Curve Period	25
Contemporary Anatomic Criteria and Clinical Outcomes With Transcatheter Mitral Repair	25
Does CRT Reduce Health Care–Related Costs in Patients With ANOCA?	24
Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis	24
Fetal Atrial Septal Intervention for HLHS With Restrictive Septum: Promising Progress, Persistent Questions	24
Comparative Outcomes of Transcatheter Edge-to-Edge Repair and Tricuspid Valve Surgery for Isolated Tricuspid Valve Regurgitation	24
Why Age Matters: Revascularization Strategy and Outcomes in Young and Elderly With CLTI	24
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients	23
Expecting the Unexpected: Insights and Uncertainties From the ALTERRA Trial 3-Year Results	23
Mechanisms Matter: Combining Invasive Metrics to Better Define Microvascular Dysfunction	23
Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance	23
Outcomes of Transcatheter Tricuspid Edge-to-Edge Repair in Patients With Right Ventricular Dysfunction	22
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk	22
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients	22
Editors and Editorial Board	22
Clinical Value of Single-Projection Angiography–Derived FFR in Noninfarct-Related Artery	22
Reperfusion Delays and Outcomes Among Patients With ST-Segment–Elevation Myocardial Infarction With and Without Cardiogenic Shock	22
Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge Repair	22
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses	22
Graft Patency and Clinical Outcomes in Patients With Radial Artery Grafts Previously Instrumented for Cardiac Catheterization	21
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis	21
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis	21
Hybrid Versus Percutaneous Left Atrial Decompression in Infants With Hypoplastic Left Heart Variants and an Intact or Highly Restrictive Atrial Septum: A Multicenter PICES Study	21
Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry	21
Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial	20
Extended Rhythm Monitoring to Assess for Ventricular Arrhythmias After Transcatheter Pulmonary Valve Replacement With the Harmony Valve	20
Temporal Trends and Predictors of Access Site Crossover During PCI in Contemporary Practice: A Report From the NCDR CathPCI Registry	20
Large Animal Translational Validation of 3 Mitral Valve Repair Operations for Mitral Regurgitation Using a Mitral Valve Prolapse Model: A Comprehensive In Vivo Biomechanical Engineering Analysis	20
Enhancing Coronary Revascularization Decisions: The Promising Role of Large Language Models as a Decision-Support Tool for Multidisciplinary Heart Team	20
Zipping Versus Clover Repair in Transcatheter Edge-to-Edge Tricuspid Repair: Insights From the TRI-SPA Registry	19
More Is Not Always Better: Reassessing Acetylcholine Provocation in the Diagnosis of Coronary Vasospasm	19

Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI	19
DanGers of Delays in Cardiogenic Shock: Benefit Persists But Attenuates	19
Still a Long Way to the Precision Medicine of Antiplatelet Strategy After Percutaneous Coronary Intervention	19
Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation	19
What Predicts the Success of Alcohol Septal Ablation?: The Myocardium Counts, After All	19
Response to Letter by Piriou et al Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”	19
Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry	18
Cardiac Structural Complications in TAVR: A Persistent Challenge in the Modern Era	18
Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA	18
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial	18
Invasive Coronary Function Testing in Patients With Prior PCI Who Have Persistent ANOCA	18
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial	18
Associations of Sarcopenia and Body Composition Measures With Mortality After Transcatheter Aortic Valve Replacement	18
Technical Advances and Outcomes of Fetal Atrial Septal Intervention for Restrictive or Intact Atrial Septum	18
Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Outcome in Patients With ST-Segment–Elevation Myocardial Infarction	17
Sirolimus-Coated Balloons for In-Stent Restenosis: The Evolution of PCI	17
Direct Oral Anticoagulants Versus Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Trials	17
Letter by Skalidis et al Regarding Article, “Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Stu	17
Invasive or CT Angiography: Alternative or Complementary Imaging Tools After CABG?	17
Transcatheter Mitral Valve-in-Valve Replacement as a First-Line Treatment for Bioprosthetic Valve Failure	17
Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair	17
Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic Stenosis	17
Metrics to Assess Quality Following Percutaneous Coronary Intervention Complications: Is “Failure to Rescue” an Answer?	17
Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk	16
Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement	16
Comprehensive Diagnosis of Myocardial Ischemia of Obstructive and Nonobstructive Origin With a Wire-Free Diagnostic Strategy	16
Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry	16
Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future Directions	15
Timing of ECLS Initiation and Outcomes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Predefined Subanalysis of the ECLS-SHOCK Trial	15
Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study	15
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio	14
Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis	14
Stent-Edge Hinge Movement in a Calcified Lesion Is Associated With Increased Prevalence of a Calcified Nodule at Follow-Up	14
Expanding Transcatheter Tricuspid Valve Replacement Applicability—Beyond Device Iterations	14
Pulmonary Artery Systolic Pressure Trajectories After Transcatheter Edge-to-Edge Repair in Atrial and Ventricular Secondary Mitral Regurgitation	14
Novel Real-Time Fluoroscopic Assessment Method of THV Expansion Following Balloon-Expandable TAVR	14
Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial	13
Coronary Artery Obstruction After Transcatheter Aortic Valve Implantation: Past, Present, and Future	13
Impact of Intensity of Vascular Care Preceding Major Amputation Among Patients With Chronic Limb-Threatening Ischemia	13
Feasibility of Redo-Transcatheter Aortic Valve Replacement in Sapien Valves Based on In Vivo Computed Tomography Assessment	13
Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries	13
Transcatheter Valve Replacement in Adults With Congenital Heart Disease—The Mayo Clinic Experience	13
Challenges and Evolving Strategies in the Treatment of In-Stent Restenosis With Drug-Coated Balloons	12
Virtual FFR From Optical Coherence Tomography: A 1-Stop Shop for PCI Guidance?	12
Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves	12
Time Course of Microvascular Stunning in ST-Segment–Elevation Myocardial Infarction	12
Temporal Trends in Isolated and Concomitant Aortic Valve Replacement for Aortic Stenosis in Patients Aged <65 Years	12
PCI for Surgically Ineligible Patients: Another Piece of the Jigsaw	12
Dynamic Nature of the Hyperemic Continuum	12
Association Between Artificial Intelligence-Detected Features on the ECG and Presence of Microvascular Obstruction	12
Response by Costa et al to Letter Regarding Article, “Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation”	12
CCTA-Guided Invasive Coronary Angiography in Patients With CABG: A Multicenter, Randomized Study	11
Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction	11
Response to Letter Regarding Article, “Interpreting AI noise Driven Radiation Reduction in Coronary Angiography: The Role of Technical and Clinical Determinants”	11
TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review	11
Hemodynamic Super-Responders in Pulmonary Embolism: Optimism and Uncertainty	11
One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study	11
Statewide Initiative to Reduce Patient Radiation Doses During Percutaneous Coronary Intervention	11
FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs	11
Can TAVR Be Safely Performed in Patients With Bicuspid Aortic Valve Morphology?	11
Prognostic Impact of Left Atrial Appendage Patency After Device Closure	10
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention	10
Contrast-Derived Index of Microcirculatory Resistance: A Novel Index for Measuring Coronary Microvascular Resistance	10
Editors and Editorial Board	10
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA)	10
Prospective Validation of the MIRACLE ₂ Score for Early Neurological Stratification After Out-of-Hospital Cardiac-Arrest: The GLOBAL-MIRACLE Registry	10
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort	10
Coronary Sinus Reduction: Can Device-Based Therapy Improve Coronary Microvascular Function?	10
CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?	10
Correction to: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention	10
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction	10
Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches	10
Seeing More With Less: AI to Reduce Radiation Exposure in the Cath Lab	10
Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions	10
Response by Brilakis et al to Letter Regarding Article, “Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future”	10
Ultra-Low Contrast IVUS-Guided PCI in Patients With Severe Chronic Kidney Disease: An Observational Prospective Study	10
Intravascular Imaging-Guided Versus Angiography-Guided Complex PCI in Patients With High Bleeding Risk: A Secondary Analysis of the RENOVATE-COMPLEX PCI Trial	9
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial	9
In-Hospital ST-Segment–Elevation Myocardial Infarction: Years Later, Still the Same?	9
Technical Success of Fetal Aortic Valvuloplasty in Relation to Center Volumes: A Report From the International Fetal Cardiac Intervention Registry	9

Safety and Efficacy of Percutaneous Left Atrial Appendage Closure Without Preprocedural Imaging	9
Response by Maznyczka et al to Letter Regarding Article, “Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis”	9
Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I Study	9
Reno-Protective Effects of SGLT2 Inhibitors in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: Insights From the BMC2 Registry	9
Optimization of Absolute Coronary Blood Flow Measurements to Assess Microvascular Function: In Vivo Validation of Hyperemia and Higher Infusion Speeds	9
Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease	8
Clinical Features and Outcomes Among Patients With Refractory Out-of-Hospital Cardiac Arrest and an Initial Shockable Rhythm	8
Does the Timing Matter in Invasive Management of Non–ST-Segment–Elevation Acute Coronary Syndrome?	8
Evaluation of Instantaneous Wave-Free Ratio and Fractional Flow Reserve in Severe Aortic Valve Stenosis	8
A New Beat: Tracing the Journey of Transcatheter Pulmonary Valve Replacement	8
Safety and Effectiveness of Intracoronary Imaging-Guided PCI in Contemporary Practice: Insights From BMC2	8
Native and Post-Repair Residual Mitral Valve Prolapse Increases Forces Exerted on the Papillary Muscles: A Possible Mechanism for Localized Fibrosis?	8
Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval Study	8
Percutaneous Thoracic Duct Externalization and Autotransfusion in Patients With Lymphatic Failure Due to Elevated Central Venous Pressure	8
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies	8
Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials	8
Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral Access	8
Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives	8
Correction to: Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes	8
ELLIS Study: Comparative Analysis of Excimer Laser Coronary Angioplasty and Intravascular Lithotripsy on Drug-Eluting Stent as Assessed by Scanning Electron Microscopy	8
Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes?	8
Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR	8
Hemodynamics and Mid-Term Clinical Outcomes Following Valve-in-Valve TAVR With Balloon-Expandable Valves	8
Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials	8
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort	7
Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention	7
Pullback Pressure Gradient and Intravascular Imaging in Focal and Diffuse Coronary Disease: The Next Step in Precision PCI?	7
Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis	7
Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair	7
CTCA Prior to Invasive Coronary Angiography in Patients With Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilization, and Cardiac Events at 3 Years From the BYPASS-CTCA Trial	7
Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data?	7
Drug-Coated Balloons With or Without Provisional Bare Metal Stenting in Femoropopliteal Disease: No Metal Left Behind?	7
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial	7
Evolution of Cardiac Damage Following SAVR in Asymptomatic Severe Aortic Stenosis	6
Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy: Pooled Analysis From the Disrupt CAD Studies	6
Utilization and Outcomes Associated With Intravascular Ultrasound During Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)	6
First-in-Human Endovascular Aortic Root Repair (Endo-Bentall) for Acute Type A Dissection	6
Response to Letter Regarding Article, “Prospective Observational Study on the Accuracy of Predictors of Permanent Pacemaker Secondary to High-Grade Atrioventricular Conduction Block After TAVI (CONDUC	6
Hemodynamic Super-Response to Mechanical Thrombectomy in Patients With Intermediate-Risk Pulmonary Embolism	6
Left Main Coronary Artery Intervention: Respect the Circumflex	6
Subclinical Thrombosis on Valve Durability in Low-Risk Transcatheter Aortic Valve Replacement Patients: Mid-Term Data Reassuring, but Longer Follow-Up Needed	6
Coronary Atherosclerosis Phenotypes in Non–Flow-Limiting Nonculprit Lesions of Older Patients With MI Stratified by Focal and Diffuse Disease Patterns	6
Comparative Effectiveness of TAVI Platforms and Surgical Aortic Valve Replacement: A Network Meta-Analysis of Randomized Controlled Trials	6
Impact of Intravascular Ultrasound–Derived Lesion-Specific Virtual Fractional Flow Reserve Predicts 3-Year Outcomes of Untreated Nonculprit Lesions: The PROSPECT Study	6
Hemodynamic Effects of Transcatheter Tricuspid Valve Annuloplasty With Cardioband and Their Associations With Clinical Outcomes	6
Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis	6
Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials	6
Optimal Degree of Balloon-Expandable Transcatheter Valve Oversizing in Patients With Borderline Aortic Annulus Measurements: Insights From a Multicenter Real-World Experience	6
Catheter-Induced Postextrasystolic Potentiation in the Assessment of Severity of Low-Gradient Aortic Valve Stenosis	6
Response by Ulacia Flores and Bertrand to Letter Regarding Article, “Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study”	6
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study	6
Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair	6
Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves	6
Correction to: Contributors to the Growth of Same Day Discharge After Elective Percutaneous Coronary Intervention	6
Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?	6
Device-Related Findings on Computed Tomography After Transcatheter Pulmonary Valve Replacement With the Harmony Valve	6
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study	6
Anatomically Directed Lower Extremity Gene Therapy for Ulcer Healing: A Double-Blind, Randomized, Placebo-Controlled Study (LEGenD-1)	6
Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial	6
Response by Amat-Santos et al to Letter Regarding Article, “Laser Coronary Atherectomy and Polymeric Coronary Wires in Uncrossable Lesions: a Word of Caution”	6
Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage	6
Ischemia in Anomalous Aortic Origin of a Right Coronary Artery: Large Pediatric Cohort Medium-Term Outcomes	6
Physiologic Assessment of Left Main Disease: Still a Complex Art	6
Editors and Editorial Board	5
Elevated Resting Coronary Blood Flow Is Associated With Death, MI, and HF in All-Comer Patients With Chronic Coronary Syndrome	5
Risk of Aortic Root Rupture in Bicuspid Aortic Stenosis: The ABC Sizing Algorithm for SAPIEN 3 Valves	5
Prioritizing Rapid Reperfusion in ST-Segment–Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Leveraging Regionalized Systems of Care	5
Transcatheter Interventions in Adults With Fontan Palliation	5
Letter by Henry and Widmer Regarding Article, “Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction”	5
Expansion of Transcatheter Aortic Valve Implantation and Mortality due to Aortic Stenosis Between 2010 and 2019	5
Transcatheter Patent Ductus Arteriosus Closure in Premature Infants: A Multicenter Retrospective Study Comparing Available Devices	5
Drug-Coated Balloon Use in Contemporary Coronary Angioplasty: Is the Jury Still Out?	5
Prediction of Heart Failure Hospitalization or Death After TAVR	5
Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel Disease	5
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial	5
Impact of Bifurcation Lesions on Outcomes After FFR-Guided PCI or CABG	5
Dynamic Change of Coronary Artery Geometry After Bioadaptor Implantation: A Single-blind Randomized Controlled Trial	5
Redo-TAVR Feasibility After SAPIEN 3 Stratified by Implant Depth and Commissural Alignment: A CT Simulation Study	5
Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies	5
Association Between Neurological Status and Outcomes in Cardiac Arrest Patients Undergoing PCI in Contemporary Practice: Insights From BMC2	5
Procedural and Clinical Outcomes According to Ultrasound-Guided Access in TAVI: A Propensity-Matched Comparative Subanalysis From the PULSE Registry	5
Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves	5
Calculating Relative Lung Perfusion Using Fluoroscopic Sequences and Image Analysis: The Fluoroscopic Flow Calculator	5
Unfolding Mystery of Aortic Transcatheter Valve Doppler Gradient and Clinical Outcomes	5
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia	5
Physician-Modified Endograft–Facilitated Transcatheter Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract	5
Prospective Observational Study on the Accuracy of Predictors of Permanent Pacemaker Secondary to High-Grade Atrioventricular Conduction Block After TAVI (CONDUCT-TAVI)	4
Unraveling the Maze of De-Escalation Strategies in Acute Coronary Syndromes	4
Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial	4
Genotype-Guided P2Y ₁₂ -Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI	4
Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision	4
Enhancing Regional ST-Segment–Elevation Myocardial Infarction Care: A Shock to the System	4
Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial	4
Letter by Peled et al Regarding Article, “Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention”	4
Letter by Shah Regarding Article, “Patent Foramen Ovale Closure in Patients With and Without Nickel Hypersensitivity: A Randomized Trial”	4